Literature DB >> 20811965

Clinical trials report: pazopanib for advanced renal cell carcinoma: comments on the results from the phase 3 study.

Jon Jones1, Joachim W Thüroff.   

Abstract

Entities:  

Year:  2010        PMID: 20811965     DOI: 10.1007/s11934-010-0139-z

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  1 in total

Review 1.  Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma.

Authors:  Manuela Schmidinger; Joaquim Bellmunt
Journal:  Cancer Treat Rev       Date:  2010-02-16       Impact factor: 12.111

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.